Abstract
Purpose
Closed vitrification poses a risk of adversely affecting embryo development, while it may minimize the risk of contamination. We assessed the effects of closed-system human embryo vitrification on fetal development after implantation, neonatal outcome, and clinical safety.
Methods
This was a retrospective cohort study conducted at a private fertility clinic. A total of 875 vitrified-warmed blastocysts that were single-transferred under hormone-replacement cycles between November 2011 and December 2013 were randomly divided into two groups (closed vitrification, n 313; open vitrification, n 562) after receiving the patients’ consent forms. Developmental competence after implantation, including gestational age, birth weight, sex, Apgar score, and anomalies of newborns, after the transfer of blastocysts vitrified by closing vitrification was compared with that obtained in the case of open vitrification.
Results
There were no significant differences between the use of closed and open vitrification systems in embryo development after implantation, gestational age, birth weight, sex ratio, Apgar score, and congenital anomalies of newborns.
Conclusion
Human embryos can be vitrified using a closed vitrification system without impairment of neonatal development.
Similar content being viewed by others
References
Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature. 1983;305:707–9.
Rall W, Fahy G. Ice-free cryopreservation of mouse embryos at −196 °C by vitrification. Nature. 1985;313:573–5.
Liebermann J, Tucker MJ. Effect of carrier system on the yield of human oocytes and embryos as assessed by survival and developmental potential after vitrification. Reproduction. 2002;124:483–9.
Mazur P, Seki S, Pinn IL, Kleinhans FW, Edashige K. Extra- and intracellular ice formation in mouse oocytes. Cryobiology. 2005;51:29–53.
Vajta G, Nagy ZP. Are programmable freezers still needed in the embryo laboratory? Review on vitrification. Reprod Biomed Online. 2006;12:779–96.
Mazur P, Cole KW, Hall WH, Schreuders PD, Mahowald AP. Cryobiological preservation of Drosophila embryos. Science. 1992;258:1932–5.
Huang JY, Chen HY, Tan SL, Chian RC. Effect of choline-supplemented sodium-depleted slow freezing versus vitrification on mouse oocyte meiotic spindles and chromosome abnormalities. Fertil Steril. 2007;88:1093–100.
Lane M, Gardner DK. Vitrification of mouse oocytes using a nylon loop. Mol Reprod Dev. 2001;58:342–7.
Nedambale TL, Dinnyes A, Groen W, Dobrinsky JR, Tian XC, Yang X. Comparison on in vitro fertilized bovine embryos cultured in KSOM or SOF and cryopreserved by slow freezing or vitrification. Theriogenology. 2004;62:437–49.
Valojerdi MR, Salehnia M. Developmental potential and ultrastructural injuries of metaphase II (MII) mouse oocytes after slow freezing or vitrification. J Assist Reprod Genet. 2005;22:119–27.
Loutradi KE, Kolibianakis EM, Venetis CA, Papanikolaou EG, Pados G, Bontis I, et al. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil Steril. 2008;90:186–93.
Martinez-Burgos M, Herrero L, Megias D, Salvanes R, Montoya MC, Cobo AC, et al. Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage. Fertil Steril. 2011;95:374–7.
Bielanski A. The potential for animal and human germplasm contamination through assisted reproductive technologies. Trends Reprod Biol. 2006;2:13–36.
Bielanski A, Vajta G. Risk of contamination of germplasm during cryopreservation and cryobanking in IVF units. Hum Reprod. 2009;24:2457–67.
Kuwayama M, Vajta G, Leda S, Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod Biomed Online. 2005;11:608–14.
Isachenko V, Montag M, Isachenko E, Zaeva V, Krivokharchenko I, Shafei R, et al. Aseptic technology of vitrification of human pronuclear oocytes using open-pulled straws. Hum Reprod. 2005;20:492–6.
Isachenko V, Katkov II, Yakovenko S, Lulat AG, Ulug M, Arvas A, et al. Vitrification of human laser treated blastocysts within cut standard straws (CSS): novel aseptic packaging and reduced concentrations of cryoprotectants. Cryobiology. 2007;54:305–9.
Vanderzwalmen P, Ectors F, Grobet L, Prapas Y, Panagiotidis Y, Vanderzwalmen S, et al. Aseptic vitrification of blastocysts from infertile patients, egg donors and after IVM. Reprod Biomed Online. 2009;19:700–7.
Larman MG, Gardner DK. Vitrification of mouse embryos with super-cooled air. Fertil Steril. 2011;95:1462–6.
AbdelHafez F, Xu J, Goldberg J, Desai N. Vitrification in open and closed carriers at different cell stages: assessment of embryo survival, development. DNA integrity and stability during vapor phase storage for transport. BMC Biotechnol. 2011;11:29.
Panagiotidis Y, Kasapi E, Goudakou M, Papatheodorou A, Pasadaki T, Petousis S, et al. Open vs. closed vitrification system for the cryopreservation of human blastocysts: a prospective randomized study. Hum Reprod. 2012;27:i59–60.
Papatheodourou A, Vanderzwalmen P, Panagiotidis Y, Kasapi L, Goudakou M, Pasadaki T, et al. Open versus closed oocyte vitrification system: a prospective randomized sibling-oocyte study. Hum Reprod. 2012;27:i72.
De Munck N, Verheyen G, Stoop D, Van Landuyt L, Van de Velde H. Survival and post-warming in vitro competence of human oocytes after high-security closed system vitrification. Hum Reprod. 2012;27:i72–3.
Hashimoto S, Amo A, Hama S, Ohsumi K, Nakaoka Y, Morimoto Y. A closed system supports the developmental competence of human embryos after vitrification. J Assist Reprod Genet. 2013;30:371–6.
Desai NN, Goldberg JM, Austin C, Falcone T. The new Rapid-i carrier is an effective system for human embryo vitrification at both the blastocyst and cleavage stage. Reprod Biol Endocrinol. 2013;11:41.
Chen Y, Zheng X, Yan J, Qiao J, Liu P. Neonatal outcomes after the transfer of vitrified blastocysts: closed versus open vitrification system. Reprod Biol Endocrinol. 2013;11:107.
Kupka MS, Ferraretti AP, de Mouzon J, Erb K, D’Hooghe T, Castilla JA, et al. The European IVF-monitoring (EIM) and consortium, for the European society of human reproduction and embryology (ESHRE). Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE. Hum Reprod. 2014;29:2099–113.
Gardner DK, Lane M. Culture and selection of viable human blastocysts: a feasible proposition for human IVF. Hum Reprod Update. 1997;3:367–82.
Rehman KS, Bukulmez O, Langley M, Carr BR, Nackley AC, Doody KM, et al. Late stages of embryo progression are a much better predictor of clinical pregnancy than early cleavage in intracytoplasmic sperm injection and in vitro fertilization cycles with blastocyst-stage transfer. Fertil Steril. 2007;87:1041–52.
Hashimoto S, Amo A, Hama S, Ito K, Nakaoka Y, Morimoto Y. Growth retardation in human blastocysts increases the incidence of abnormal spindles and decreases implantation potential after vitrification. Hum Reprod. 2013;28:1528–35.
Hashimoto S, Nishihara T, Murata Y, Oku H, Nakaoka Y, Fukuda A, et al. Medium without ammonium accumulation supports the developmental competence of human embryos. J Reprod Dev. 2008;54:370–4.
Rooney DE, Czepulkowski BH. Human cytogenetics. A practical approach. New York: Oxford University Press; 1992.
Edgar DH, Gook DA. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update. 2012;18:536–54.
Yokota Y, Sato S, Yokota M, Ishikawa Y, Makita M, Asada T, et al. Successful pregnancy following blastocyst vitrification: case report. Hum Reprod. 2000;15:1802–3.
CryoBio: pre-market notification K092398 HSV straw. 2010.
Seki S, Mazur P. The dominance of warming rate over cooling rate in the survival of mouse oocytes subjected to a vitrification procedure. Cryobiology. 2009;59:75–82.
Bonduelle M, Liebaers I, Deketelaere V, Derde MP, Camus M, Devroey P, et al. Neonatal data on a cohort of 2889 infants born after ICSI (1991–1999) and of 2995 infants born after IVF (1983–1999). Hum Reprod. 2002;19:671–94.
Budinetz TH, Mann JS, Griffin DW, Benadiva CA, Nulsen JC, Engmann LC. Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization. Fertil Steril. 2014;102:753–8.
Koike A, Nakaoka Y, Tarui S, Ohgaki A, Sugihara K, Nagata F, et al. Analysis of clinical outcomes from pregnancies achieved by frozen-thawed embryo transfer. J Fertil Implant. 2008;25:219–22.
Acknowledgments
This work was supported in part by a grant from the Japan Society for the Promotion of Science (JPS-RFTF 23580397 to S.H.).
Conflicts of interest
None of the authors has a conflict of interest to disclose. Some of these data were presented at the 69th Annual Meeting of the American Society for Reproductive Medicine, October 12–17, 2013 in Boston, and a part of the data of viability after vitrification was reported in J Assist Reprod Genet 2013; 30:371–376.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule Closed vitrification, which eliminates the risk of cross-contamination during cooling and storage in liquid nitrogen, does not cause a debilitating effect on human embryo growth and development.
Rights and permissions
About this article
Cite this article
Iwahata, H., Hashimoto, S., Inoue, M. et al. Neonatal outcomes after the implantation of human embryos vitrified using a closed-system device. J Assist Reprod Genet 32, 521–526 (2015). https://doi.org/10.1007/s10815-015-0431-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-015-0431-4